Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $34.49 and last traded at $34.43, with a volume of 489599 shares changing hands. The stock had previously closed at $33.50.
Wall Street Analyst Weigh In
OPCH has been the topic of several research reports. Barrington Research raised their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. JMP Securities reissued a "market outperform" rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. UBS Group began coverage on Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price on the stock. Finally, JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $33.00.
View Our Latest Stock Report on Option Care Health
Option Care Health Trading Down 0.7 %
The stock has a market capitalization of $5.62 billion, a PE ratio of 28.58, a P/E/G ratio of 2.30 and a beta of 1.33. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business's fifty day moving average is $29.61 and its 200-day moving average is $28.18.
Insider Buying and Selling at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Option Care Health
Institutional investors have recently made changes to their positions in the business. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health in the fourth quarter valued at $26,000. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC lifted its position in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC lifted its position in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Public Employees Retirement System of Ohio increased its holdings in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.
About Option Care Health
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
